Anti-Infective · General Oral/Topical
VOOFLOL-MS
Ofloxacin 50 mg + Metronidazole 120 mg + Simethicone 10 mg
Manufactured at WHO-GMP certified facility by BIOFRIL HEALTHCARE. Available for hospital tender supply, ICU pharmacy, and PCD franchise distribution across India.
Product Specifications
VOOFLOL-MS at a Glance
| Brand Name | VOOFLOL-MS |
|---|---|
| Composition | Ofloxacin 50 mg + Metronidazole 120 mg + Simethicone 10 mg |
| Therapeutic Category | Anti-Infective |
| Division | General Oral/Topical |
| Pack / Presentation | Susp. PET BOTTLE 60 ML |
| Storage | Store below 25°C. Protect from light. |
| Manufacturer | BIOFRIL HEALTHCARE Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Schedule H — Sold on prescription of a Registered Medical Practitioner only |
Clinical Use
Indications & Clinical Applications
VOOFLOL-MS (Ofloxacin 50 mg + Metronidazole 120 mg + Simethicone 10 mg) is indicated for the treatment of conditions in which Ofloxacin 50 mg therapy is clinically appropriate. For complete prescribing information please refer to the official product insert.
Submit Enquiry for VOOFLOL-MS
PCD franchise · Hospital tender supply · Bulk procurement